-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Shenzhen Haipurui Pharmaceutical Group Co.
, Ltd.
, a well-known multinational pharmaceutical company, through its wholly-owned grandson company Shenzhen Tiandao Pharmaceutical Co.
, Ltd.
("Tiandao"), donated a well-functioning pilot injection production line to Shenzhen Science and Technology Review Management Center for free to support Shenzhen Municipal Science and Technology Center incubator review management, support and service the local bio-pharmaceutical companies, big boost industrial development and upgrading of Shenzhen Bay innovation
.
This production line is located in No.
10 biological incubator base, Gaoxinzhong Road, Nanshan District, Shenzhen.
It has passed EU and China GMP certification and is used for the pilot production of enoxaparin sodium injection
.
This production line is also the starting point for Hai Purui to become the world's leading enoxaparin injection production and sales company
Enoxaparin Sodium Injection is a classic drug with clear curative effect.
It is suitable for the prevention and treatment of venous thrombosis and embolic diseases, as well as the anticoagulation treatment of acute coronary syndrome, especially thrombosis related to orthopedics or general surgery.
Prevention and treatment have a wide range of clinical applications
.
Recently, the World Health Organization (WHO), the National Institute of Health and Clinical Optimization, and the American Society of Hematology (ASH) have issued guidelines recommending the use of low-molecular-weight heparin to prevent and treat severe complications related to the new coronavirus infection
It started from this pilot production line.
Over the past 16 years, Tiandao has successively passed GMP certification in more than ten countries, and its enoxaparin sodium injection has been exported to 51 countries, including the United States and the European Union, which are difficult to enter
.
In Europe, Tiandao became the first Chinese company to obtain approval for a biosimilar drug, and it has now been included in the medical insurance systems of 13 major EU countries, as well as the United Kingdom and Switzerland
As a business card for China's quality manufacturing and the export of high-end preparations, Tiandao's development is the epitome of Shenzhen's speed and innovation incubation
.
The innovative spirit of "dare to try, open and inclusive" is engraved in Shenzhen's genes
Wang Hui, head of Shenzhen Science and Technology Review Management Center, said: “The biomedical industry is one of the seven strategic emerging industries identified by China, and it is also a pillar industry that Shenzhen focuses on fostering
.
With support and incubation, as a business card of Shenzhen and China's quality manufacturing, it has been widely recognized overseas.
Li Li, Chairman of Hai Purui, said: "Thank you for the help and support of Shenzhen Science and Technology Review and Management Center for Hai Purui
.
The responsibility and original intention of pharmaceutical companies is to bring safe, effective and affordable drugs to patients around the world, and to heal patients' ailments.
